
Join colleagues from across the region for a Joint Annual Meeting of the Virginia Society of Otolaryngology and the West Virginia Academy of Otolaryngology, taking place May 7–9, 2026, at The Greenbrier Resort in White Sulphur Springs, West Virginia. This collaborative meeting will feature outstanding education, dynamic discussion, and valuable networking in one of the country’s most iconic resort settings.
Highlights include guest speakers: Dr. Travis Tollefson will present on International Humanitarian Missions and Dr. Michael Cunningham will share Surgical Management of Pediatric Obstructive Sleep Apnea: Does Technique Matter? and Professionalism, a tale of two cases.
Attendees can also look forward to interactive panel discussions on sleep, rhinology, contemporary management of facial nerve disorders, head & neck topics, otology, pediatric “scary cases,” and global humanitarian work.
Additional sessions include Dermatologic disorders in Head and Neck and Vascular Malformations in Head and Neck. Resident research presentations and the always-popular Academic Bowl returns as well.
ABOUT THE MEETING
Thursday May 7
Friday, May 8
Saturday, May 9
We look forward to seeing you there!
The CAMC Institute designates this live activity for a maximum of 13.75 hours for AMA PRA Category I Credit(s)™ for Friday, May 9, and Saturday, May 10. Physicians should only claim credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by the West Virginia Academy of Otolaryngology (WVAO) and CAMC Institute for Academic Medicine. CAMC Institute for Academic Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
It is the policy of the CAMC Institute for Academic Medicine that any faculty (speaker) who makes a presentation at a program designated for AMA Physician’s Recognition Award (PRA) Category I or II must disclose any financial interest or other relationship; (i.e. spouses/partners, grants, research support, consultant, honoraria) that faculty member has with the manufacturer(s) of any commercial product(s) that may be disclosed in the educational presentation. Program Planning Committee Members must also disclose any financial interest or relationship with commercial industry that may influence their participation in this conference. The following disclosures have been shared: Dr. Cunningham is a consultant with Plural Publishing; Dr. Goudy is a major shareholder with Dr. Noze Best and Oridivus; Dr. Lam has research support from AstraZeneca, is a consultant for Regeneron/Sanofi, and is on the Speakers’ Bureau for GSK, Eli Lilly and Paratek; Dr. Tollefson has grants from AO Foundation and Johnson and Johnson. Faculty relationships with industry, if any, will be made available on-site and disclosure made from the podium to the participants. All presentations are HIPAA compliant.


